Results for this period
Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
The medical equipment market drove overall performance, while the semiconductor and LCD markets also remained strong. In Japan, the company promoted sales expansion through solution-based sales proposals, while overseas it pursued market expansion as its sales policy. In the United States and Europe, foreign-exchange translation effects from the weaker yen also contributed. The increase in profit was mainly due to higher revenue and other factors.
None
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 September 2026 |
| Net Sales | ¥26,893 million (YoY +18.5%) |
| Operating profit | ¥3,990 million (YoY +46.4%) |
| Ordinary income | ¥4,577 million (YoY +41.7%) |
| Profit attributable to owners of the parent | ¥3,392 million (YoY +47.5%) |
| Net income per share | ¥152.85 |
| Equity ratio | End of the current fiscal period 74 / End of previous period 74 |
| Total assets | ¥60,374 million |
| Net assets | ¥44,784 million |
| Full-year earnings forecast | Net Sales ¥54,175 million (YoY +13.6%) / Operating profit ¥7,537 million (YoY +27.2%) / Ordinary income ¥8,655 million (YoY +28.7%) / Net income ¥6,437 million (YoY +33.1%) |
| Revision to Earnings Forecast | No revision |
| Annual Dividend Forecast | 77 yen → 112 yen |
| Regional sales | ¥12,384 million (YoY +17.8%), ¥4,562 million (YoY +15.4%), ¥3,540 million (YoY +23.8%), ¥1,928 million (YoY +36.8%), ¥3,275 million (YoY +17.6%) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥2,164 thousand / Extraordinary loss Loss on disposal of non-current assets ¥1,606 thousand |
| Disclosure regarding the going concern assumption | None |
| Change in accounting policy | Changes due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None |
| Changes in the scope of consolidation | No material changes (0 additions, 0 exclusions) |
| Availability of Supplementary Financial Results Materials | Available |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 22,490,910 |
| Treasury Shares at Period-End | 217,710 |
| Factors Behind Changes in Business Performance | The medical equipment market drove overall performance, while the semiconductor and LCD markets also remained strong. In Japan, the company promoted sales expansion through solution-based sales proposals, while overseas it pursued market expansion as its sales policy. In the United States and Europe, foreign-exchange translation effects from the weaker yen also contributed. The increase in profit was mainly due to higher revenue and other factors. |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The medical equipment market drove overall performance, while the semiconductor and LCD markets also remained strong. In Japan, the company promoted sales expansion through solution-based sales proposals, while overseas it pursued market expansion as its sales policy. In the United States and Europe, foreign-exchange translation effects from the weaker yen also contributed. The company explained the increase in profit as being “mainly due to higher revenue and other factors.”